Cell surface fucosylation does not affect development of colon tumors in mice with germline Smad3 mutation

Tumor Biology

Volumn 28, Issue 2, 2007, Pages 77-83

  Domino, Steven E ^a,b   Karnak, David M ^a   Hurd, Elizabeth A ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Carbohydrates; Colon cancer; Fucosyltransferase; Glycosylation; Transforming growth factor signaling; Transgenic mouse; Ulex europaeus agglutinin I; (1,2)Fucose

Indexed keywords

FUCOSYLTRANSFERASE; GLYCAN DERIVATIVE; SIGNAL PEPTIDE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

AGGLUTINATION TEST; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SURFACE; COLON TUMOR; COLORECTAL TUMOR; CONTROLLED STUDY; FUCOSYLATION; GENE EXPRESSION; GENE MUTATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR VOLUME;

EID: 33847251585     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099153     Document Type: Article

References (34)

1. Hart GW, Lowe JB, Sathyamoorthy N: Glycobiology and cancer: meeting summary and future directions. Cancer Biol Ther 2004;3:233-237.
2. Varki A, Marth J: Oligosaccharides in vertebrate development. Semin Dev Biol 1995;6:127-138.
3. Brockhausen I: Pathways of O-glycan biosynthesis in cancer cells. Biochim Biophys Acta 1999;1473:67-95.
4. Sun J, Thurin J, Cooper HS, Wang P, Mackiewicz M, Steplewski Z, Blaszczyk-Thurin M: Elevated expression of H type GDP-L-fucose: beta-D-galactoside alpha-2-L-fucosyltransferase is associated with human colon adenocarcinoma progression. Proc Natl Acad Sci USA 1995;92:5724-5728.
5. Goupille C, Hallouin F, Meflah K, LePendu J: Increase of rat colon carcinoma cells tumorigenicity by alpha(1-2)fucosyltransferase gene transfection. Glycobiology 1997;7:221-229.
6. Hallouin F, Goupille C, Bureau V, Meflah K, Le Pendu J: Increased tumorigenicity of rat colon carcinoma cells after alpha1,2-fucosyltransferase FTA anti-sense cDNA transfection. Int J Cancer 1999;80:606-611.
7. Labarriere N, Piau J, Otry C, Denis M, Lustenberger P, Meflah K, LePendu J: H blood group antigen carried by CD44V modulates tumorigenicity of rat colon carcinoma cells. Cancer Res 1994;54:6275-6281.
8. Galanina O, Hallouin F, Goupille C, Bovin N, Le Pendu J: Detection of a potential receptor for the H-blood-group antigen on rat colon-carcinoma cells and normal tissues. Int J Cancer 1998;76:136-140.
9. Zhu Y, Richardson J, Parada LF, Graff JM: Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998;94:703-714.
10. Threadgill DW, Yee D, Matin A, Nadeau JH, Magnuson T: Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain. Mamm Genome 1997;8:390-393.
11. Domino SE, Zhang L, Gillespie PJ, Saunders TL, Lowe JB: Deficiency of reproductive tract alpha(1,2)fucosylated glycans and normal fertility in mice with targeted deletions of the FUT1 or FUT2 alpha(1,2)fucosyltrans ferase locus. Mol Cell Biol 2001;21:8336-8345.
12. Domino SE, Zhang L, Lowe JB: Molecular cloning, genomic mapping, and expression of two secretor blood group alpha (1,2)fucosyltransferase genes differentially regulated in mouse uterine epithelium and gastrointestinal tract. J Biol Chem 2001;276:23748-23756.
13. Domino SE, Hiraiwa N, Lowe JB: Molecular cloning and tissue-specific expression of a murine alpha(1,2)fucosyltransferase expressed in thymic and epididymal epithelial cells. Biochem J 1997;327:105-115.
14. Yonezawa S, Nakamura T, Tanaka S, Sato E: Glycoconjugate with Ulex europaeus agglutinin-I-binding sites in normal mucosa, adenoma, and carcinoma of the human large bowel. J Natl Cancer Inst 1982;69:777-785.
15. Hurd EA, Holmen JM, Hansson GC, Domino SE: Gastrointestinal mucins of Fut2-null mice lack terminal fucosylation without affecting colonization by Candida albicans . Glycobiology 2005;15:1002-1007.
16. Takiyama T, Woutersen R, Pour P: Ulex europaeus -I: a marker for differentiation of (pre)cancerous lesions induced in the rat pancreas by azaserine. Carcinogenesis 1988;9:2087-2092.
17. Sherwood AL, Holmes EH: Cloning and expression of the catalytic domain from rat hepatoma H35 cell GDP-fucose:GM1 alpha 1 → 2fucosyltransferase, an enzyme which is activated during early stages of chemical carcinogenesis in rat liver. Arch Biochem Biophys 1998;355:215-221.
18. Ambros R, Kurman R: Association of Ulex europaeus agglutinin I binding with invasion of endometrial carcinoma. Int J Gynecol Pathol 1993;12:301-306.
19. Valli M, Gallanti A, Bozzaro S, Trinchera M: Beta-1,3- galactosyltransferase and alpha-1,2-fucosyltransferase involved in the biosynthesis of type-1-chain carbohydrate antigens in human colon adenocarcinoma cell lines. Eur J Biochem 1998;256:494-501.
20. Hallouin F, Goupille C, le Cabellec M, Bara J, le Pendu J: Expression of A and H bloodgroup and of CD44 antigens during chemical rat colonic carcinogenesis. Glycoconj J 1997;14:801-808.
21. Asao T, Nagamachi Y, Morinaga N, Shitara Y, Takenoshita S, Yazawa S: Carcinoma-related alterations of glycosyltransferases in human tissues. Cancer 1995;75:1539-1544.
22. Mas E, Pasqualini E, Caillol N, El Battari A, Crotte C, Lombardo D, Sadoulet MO: Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines. Glycobiology 1998;8:605-613.
23. Fukushima K, Hara-Kuge S, Seko A, Ikehara Y, Yamashita K: Elevation of alpha2 → 6 sialyltransferase and alpha1 → 2 fucosyltransferase activities in human choriocarcinoma. Cancer Res 1998;58:4301-4306.
24. Dennis JW, Granovsky M, Warren CE: Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta 1999;1473:21-34.
25. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW: Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 2000;6:306-312.
26. Zipin A, Israeli-Amit M, Meshel T, Sagi-Assif O, Yron I, Lifshitz V, Bacharach E, Smorodinsky NI, Many A, Czernilofsky PA, Morton DL, Witz IP: Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells. Cancer Res 2004;64:6571-6578.
27. Rapoport E, Pendu JL: Glycosylation alterations of cells in late phase apoptosis from colon carcinomas. Glycobiology 1999;9:1337-1345.
28. Janin N: A simple model for carcinogenesis of colorectal cancers with microsatellite instability. Adv Cancer Res 2000;77:189-221.
29. Datto MB, Frederick JP, Pan L, Borton AJ, Zhuang Y, Wang XF: Targeted disruption of Smad3 reveals an essential role in transforming growth factor beta-mediated signal transduction. Mol Cell Biol 1999;19:2495-2504.
30. Yang X, Letterio JJ, Lechleider RJ, Chen L, Hayman R, Gu H, Roberts AB, Deng C: Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta. EMBO J 1999;18:1280-1291.
31. Le Pendu J, Marionneau S, Cailleau-Thomas A, Rocher J, Le Moullac-Vaidye B, Clement M: ABH and Lewis histo-blood group antigens in cancer. APMIS 2001;109:9-31.
32. Bureau V, Marionneau S, Cailleau-Thomas A, Le Moullac-Vaidye B, Liehr T, Le Pendu J: Comparison of the three rat GDP-L-fucose: beta-D-galactoside 2-alpha-L-fucosyltransferases FTA, FTB and FTC. Eur J Biochem 2001;268:1006-1019.
33. Aubert M, Panicot L, Crotte C, Gibier P, Lombardo D, Sadoulet MO, Mas E: Restoration of alpha(1,2) fucosyltransferase activity decreases adhesive and metastatic properties of human pancreatic cancer cells. Cancer Res 2000;60:1449-1456.
34. Goupille C, Marionneau S, Bureau V, Hallouin F, Meichenin M, Rocher J, Le Pendu J: Alpha1,2fucosyltransferase increases resistance to apoptosis of rat colon carcinoma cells. Glycobiology 2000;10:375-382.